Cargando…

Retracted: Efficacy and Safety of Rituximab in the Treatment of Idiopathic Membranous Nephropathy: A Meta-Analysis

Detalles Bibliográficos
Autor principal: and Biomechanics, Applied Bionics
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567196/
https://www.ncbi.nlm.nih.gov/pubmed/37829518
http://dx.doi.org/10.1155/2023/9756164
_version_ 1785119071605358592
author and Biomechanics, Applied Bionics
author_facet and Biomechanics, Applied Bionics
author_sort and Biomechanics, Applied Bionics
collection PubMed
description
format Online
Article
Text
id pubmed-10567196
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-105671962023-10-12 Retracted: Efficacy and Safety of Rituximab in the Treatment of Idiopathic Membranous Nephropathy: A Meta-Analysis and Biomechanics, Applied Bionics Appl Bionics Biomech Retraction Hindawi 2023-10-04 /pmc/articles/PMC10567196/ /pubmed/37829518 http://dx.doi.org/10.1155/2023/9756164 Text en Copyright © 2023 Applied Bionics and Biomechanics. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
and Biomechanics, Applied Bionics
Retracted: Efficacy and Safety of Rituximab in the Treatment of Idiopathic Membranous Nephropathy: A Meta-Analysis
title Retracted: Efficacy and Safety of Rituximab in the Treatment of Idiopathic Membranous Nephropathy: A Meta-Analysis
title_full Retracted: Efficacy and Safety of Rituximab in the Treatment of Idiopathic Membranous Nephropathy: A Meta-Analysis
title_fullStr Retracted: Efficacy and Safety of Rituximab in the Treatment of Idiopathic Membranous Nephropathy: A Meta-Analysis
title_full_unstemmed Retracted: Efficacy and Safety of Rituximab in the Treatment of Idiopathic Membranous Nephropathy: A Meta-Analysis
title_short Retracted: Efficacy and Safety of Rituximab in the Treatment of Idiopathic Membranous Nephropathy: A Meta-Analysis
title_sort retracted: efficacy and safety of rituximab in the treatment of idiopathic membranous nephropathy: a meta-analysis
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567196/
https://www.ncbi.nlm.nih.gov/pubmed/37829518
http://dx.doi.org/10.1155/2023/9756164
work_keys_str_mv AT andbiomechanicsappliedbionics retractedefficacyandsafetyofrituximabinthetreatmentofidiopathicmembranousnephropathyametaanalysis